Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-06-04 00:00:00 ET · period of report 2025-06-02 · accession 0001415889-25-015570 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-04 | 2025-06-02+ | MIRM | Ramasastry Saira | Dir | S - Sale+OE | $46.06 | -8,203 | 0 | -100% | -$377.8K |
| D | 2025-06-04 | 2025-06-03 | MIRM | Ramasastry Saira | Dir | M - OptEx | $14.12 | +2,500 | 2,500 | New | +$35.3K |
| D | 2025-06-04 | 2025-06-03 | MIRM | Ramasastry Saira | Dir | M - OptEx | $0.00 | -2,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-02 | S | D | 5,703 | $46.20 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-03 | M | A | 2,500 | $14.12 | 2,500 | D | — | — | |
| 3 | Common | Common Stock | 2025-06-03 | S | D | 2,500 | $45.74 | 0 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2025-06-03 | M | D | 2,500 | $0.00 | 0 | D | $14.12 · 2022-05-31 to 2031-08-15 | 2,500 Common Stock |